-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Eosinophilic esophagitis (the EoE) is a chronic immune resistance mediated oesophageal, wherein the esophageal mucosa massive infiltration of eosinophils.
Eosinophilic esophagitis (the EoE) is a chronic immune resistance mediated oesophageal, wherein the esophageal mucosa massive infiltration of eosinophils.
This study is a multi-center, double-blind trial.
A total of 93 patients were included in this study, and the pre-set modified intention-to-treat analysis set included 87 patients (38 in the placebo group and 49 in the BOS group).
Figure: Using BOS to alleviate dysphagia in EoE patients
This study found that patients receiving BOS (2.
This study found that patients receiving BOS (2.
Original source:
Evan S.
Improvements in Dysphagia and Pain With Swallowing in Patients With Eosinophilic Esophagitis Receiving Budesonide Oral Suspension.
Leave a message here